RxDoctor Payments Data

Omar Torres Lozada, MD

MOHS-Micrographic Surgery · New York, NYNPI 1477578607

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 468 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations.

$12,816in general payments, 2019–2025

Across 468 payments — averaging $27.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • Galderma Laboratories, L.p.$2K
  • AbbVie$1K
  • Revance Therapeutics, Inc.$1K
  • E.r. Squibb & Sons, L.L.C.$881
  • Sanofi$851
  • plus $5K from 26 others

What the payments were for

  • Food & beverage$12,58398%
  • Education$2332%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,816 in reported general payments places this provider in the 85th percentile of 75 mohs-micrographic surgery providers in New York.

See all mohs-micrographic surgery providers in New York

Medicare billing

Part B allowed, 2024
$147,221
Medicare patients
293
Services billed
1,625

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ErivedgeVismodegib11$144,701
Metronidazole32$3,479
Betamethasone Dipropionate45$2,872
Fluorouracil29$2,509
Ammonium Lactate91$2,369
Tacrolimus17$2,178
Fluocinonide49$2,108
Desonide27$1,185
Ciclopirox38$1,162
Doxycycline Hyclate89$1,092
Triamcinolone Acetonide93$1,074
CiclopiroxCiclopirox Olamine44$938
Mupirocin62$563
ValacyclovirValacyclovir Hcl22$411
Ketoconazole27$397

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →